|
Volumn 1, Issue 5, 2001, Pages 353-366
|
The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
ANIMAL;
BIOAVAILABILITY;
CELL CULTURE;
CHEMISTRY;
DRUG SCREENING;
GUINEA PIG;
HUMAN;
METABOLISM;
METHODOLOGY;
PHARMACOKINETICS;
PHARMACOLOGY;
RABBIT;
RAT;
REVIEW;
STANDARD;
ANIMALS;
BIOLOGICAL AVAILABILITY;
CELLS, CULTURED;
DRUG EVALUATION, PRECLINICAL;
GUINEA PIGS;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PHARMACOKINETICS;
PHARMACOLOGY;
RABBITS;
RATS;
MLCS;
MLOWN;
|
EID: 0035523085
PISSN: 15680266
EISSN: None
Source Type: Journal
DOI: 10.2174/1568026013394949 Document Type: Review |
Times cited : (140)
|
References (103)
|